3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Join Shaheen Limbada, EVP Innovation & Strategy at Veristat, and Dr. Leen Kawas of Propel Bio Partners for a thought-provoking roundtable discussion on the latest trends and solutions in decentralized clinical trials.
As an executive in the biotech industry, you understand the challenges of running complex clinical trials. Patient participation and retention are crucial to the success of any trial, and decentralized solutions are becoming increasingly popular to address these challenges.
At this exclusive event, you'll have the opportunity to:
DATE: Wednesday, February 22, 2023
TIME: 11:30 am – 1:30 pm PT (lunch is included)
LOCATION: The Lighthouse restaurant Conference Room A - 685 Gateway Boulevard, South San Francisco, CA 94080
Shaheen Limbada
Executive Vice President, Innovation and Strategy
Veristat
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...